5-Amino-1MQ is a synthetic small-molecule research compound studied as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in nicotinamide metabolism and cellular methylation pathways.
Research into it has focused on NNMT inhibition, NAD⁺ metabolism, cellular energy pathways, NNMT Inhibitor Research Compound lipid metabolism, adipocyte biology, and metabolic signaling. Preclinical studies have investigated how NNMT inhibition may influence metabolic processes and energy balance.
It is not a peptide and is primarily a research compound with evidence currently centered on laboratory and preclinical studies.
Product Highlights
5-Amino-1MQ research compound
NNMT inhibitor research
Studied in NAD⁺ and nicotinamide metabolism
Investigated in cellular energy and methylation pathways
Researched in lipid and adipocyte metabolism
Suitable for laboratory and biochemical research
Potential Research Benefits of 5-Amino-1MQ
NNMT inhibition research – Studied for its ability to inhibit nicotinamide N-methyltransferase (NNMT).
NAD⁺ metabolism research – Investigated for its relationship with nicotinamide and NAD⁺-related metabolic pathways.
Cellular metabolism research – Used to study pathways involved in cellular energy and metabolic regulation.
Methylation pathway research – Investigated in relation to methyl-group metabolism and S-adenosylmethionine (SAM) utilization.
Adipocyte research – Studied in laboratory models involving fat-cell biology and adipocyte metabolism.
Lipid metabolism research – Explored for its potential effects on pathways associated with lipid and energy metabolism.
Body-weight research – Preclinical studies have investigated NNMT inhibition in relation to body-weight and metabolic regulation.
Metabolic signaling research – Provides a research tool for investigating molecular pathways associated with metabolic function.